Dr. Schor is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1027 Frederick St
Bluefield, WV 24701Phone+1 304-325-8104Fax+1 304-324-4267
Education & Training
Loyola Medicine MacNeal HospitalResidency, Internal Medicine, 1981 - 1984
University of Illinois College of MedicineClass of 1981
Certifications & Licensure
WV State Medical License 1987 - 2023
VA State Medical License 1993 - 2020
IL State Medical License 1981 - 1987- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hospice and Palliative Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Practice Fusion EHR, Practice Fusion, Inc., 2012-2013
Publications & Presentations
PubMed
- 6 citationsPhase II trial of caracemide (NSC 253272) in advanced unresectable non-small cell bronchogenic carcinoma. An Illinois Cancer Council study.Thomas E. Lad, Joel Schor, Michael Russell Mullane, Rosemary Carroll, David Chernicoff
Investigational New Drugs. 1992-03-01 - 2 citationsPhase II trial of 4' deoxydoxorubicin (DXDX) for unresectable non-small cell bronchogenic carcinoma. An Illinois Cancer Council study.Christopher Rose, Thomas E. Lad, Lary J. Kilton, Joel Schor, Steven T. Rosen
Investigational New Drugs. 1990-02-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
